For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial failures, MetaOmics-10T represents a new starting point.

By Dr. Priyom Bose, Ph.D. A sweeping genetic analysis reveals when obesity is the common thread linking chronic diseases, and when other biology is to blame. Study: Genetics identifies obesity as a ...

A new, ultra-thin metasurface is making waves in the world of optics by defying the traditional behavior of light. By ...

Scientists are exploring how DNA’s physical structure can store vast amounts of data and encode secure information.

Brooks Consulting's Chuck Brooks, a GovCon Expert, explains how AI and quantum technologies are becoming mission-critical ...

A new study reveals that sleep types are more varied than simply larks and night owls – and questions the link between rising ...

Building a culture of compliance around respiratory protection no longer relies on guesswork. CleanSpace is making it ...

T o make good decisions on any question the public needs to be well-informed, something not so easily accomplished in America’s schools. That is a key point made by Michael Kent, a recently retired ...

Face ID's one-in-a-million security rate fails with family members who share similar features, making your iPhone vulnerable ...

The loss of federal funding for a breast cancer study at Harvard underscores the uncertain future for cancer research in ...

GSK’s own proprietary platform is called Cogito Forge. It is not a standard AI search model, but one that uses ‘agents’ that can debate with each other. One proposes a target, another simulates its ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.